32 results
8-K
EX-99.1
ATOS
Atossa Therapeutics Inc
28 Jun 23
Atossa Therapeutics Announces $10M Stock Repurchase Program
9:01am
,” said Dr. Steven Quay, Atossa’s President and Chief Executive Officer. “We believe that the current macroeconomic environment along with the long
8-K
EX-99.1
actm xuqp1
15 May 23
Atossa Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update
9:10am
8-K
EX-1.1
kh64q7pdvmu45 rgp
23 Mar 21
Entry into a Material Definitive Agreement
6:01am
8-K
EX-1.1
kvah 26j3azzg5l
8 Jan 21
Entry into a Material Definitive Agreement
9:00am
8-K
EX-1.1
1srkzxix2nmdu8
21 Dec 20
Entry into a Material Definitive Agreement
9:10am
8-K
EX-1.1
5jyj4o722 fx5o3a0w
25 Sep 20
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-1.1
wwj70 l1t9wv
10 Feb 20
Entry into a Material Definitive Agreement
12:00am